PMCTPharmaCountry
    ホーム

規制動向

FDA、EMA、TGA および世界の規制動向

#Ranitidine ×

UPDATED
規制動向
2026年9月17日•1分で読めます
FDA Approves ANDA077824 for Ranitidine Tablets by Amneal Pharmaceuticals
The FDA has granted approval for ANDA077824, authorizing Amneal Pharmaceuticals’ oral ranitidine tablets in 150 mg and 300 mg strengths, now listed as discontinued.
UPDATED
規制動向
2026年8月30日•1分で読めます
FDA Approves Ranitidine Oral Syrup (ANDA077405)
The FDA has granted approval for ANDA077405, an oral Ranitidine hydrochloride syrup (15 mg/ml) manufactured by Pharmaceutical Associates, Inc., with labeling updates through 2010.
2